We are live on ! Find out more
VTAE

VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE

Delisted

VTAE was delisted on the 24th of October, 2016.

Back to rankings

98 hedge funds and large institutions have $504M invested in VITAE PHARMACEUTICALS INC COMMON STOCK in 2016 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 26 increasing their positions, 18 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

135% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 20

122% more capital invested

Capital invested by funds: $227M → $504M (+$277M)

44% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 18

38% more funds holding

Funds holding: 71 → 98 (+27)

42% less call options, than puts

Call options by funds: $1.4M | Put options by funds: $2.43M

Holders
98
Holders Change
+27
Holders Change %
+38.03%
% of All Funds
2.61%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
47
Increased
26
Reduced
18
Closed
20
Calls
$1.4M
Puts
$2.43M
Net Calls
-$1.03M
Net Calls Change
-$1.17M

Top Buyers

Rank Fund Capital Flow
1
AAM
Alpine Associates Management
Florida
+$20.6M
2
Allianz Asset Management
Allianz Asset Management
Germany
+$15.5M
3
TAL
TIG Advisors LLC
New York
+$14.9M
4
WIC
Water Island Capital
New York
+$14.5M
5
MF
Magnetar Financial
Illinois
+$12.9M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$39.8M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$36.7M
3
CAM
Cormorant Asset Management
Massachusetts
-$18.9M
4
RCM
RA Capital Management
Massachusetts
-$17M
5
BI
BVF Inc
California
-$8.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
BBP
26
Banco BTG Pactual
Brazil
$5.4M +$2.97M +258,105 New
TCM
27
Tekla Capital Management
Massachusetts
$5.23M +$2.88M +250,000 New
JP Morgan Chase
28
JP Morgan Chase
New York
$5.18M -$821K -71,270 -22%
KPF
29
K2 Principal Fund
Ontario, Canada
$4.36M +$2.4M +208,608 New
Invesco
30
Invesco
Georgia
$4.36M +$2.4M +208,179 New
HCM
31
Highbridge Capital Management
New York
$4.21M +$2.32M +201,043 New
OAC
32
OMERS Administration Corp
Ontario, Canada
$4.21M +$2.31M +201,000 New
SG Americas Securities
33
SG Americas Securities
New York
$4.17M +$2.29M +199,178 New
Morgan Stanley
34
Morgan Stanley
New York
$4.16M +$2.2M +190,883 +2,333%
GCIA
35
Gabelli & Co Investment Advisers
New York
$4.12M +$2.27M +196,992 New
Geode Capital Management
36
Geode Capital Management
Massachusetts
$3.53M +$173K +15,048 +10%
Handelsbanken Fonder
37
Handelsbanken Fonder
Sweden
$3.2M – – –
HM
38
Harvest Management
New York
$2.93M +$1.61M +140,000 New
PCM
39
Prelude Capital Management
New York
$2.65M +$1.46M +126,701 New
Ameriprise
40
Ameriprise
Minnesota
$2.45M +$1.35M +117,148 New
HA
41
Havens Advisors
New York
$2.17M +$1.19M +103,760 New
BIM
42
BlackRock Investment Management
Delaware
$2.11M -$2.04K -177 -0.2%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$1.83M -$4.28K -372 -0.4%
Charles Schwab
44
Charles Schwab
California
$1.78M +$48.7K +4,226 +5%
CCM
45
Century Capital Management
Massachusetts
$1.75M -$1.31M -113,318 -57%
Goldman Sachs
46
Goldman Sachs
New York
$1.69M +$250K +21,751 +37%
TC
47
TFS Capital
Pennsylvania
$1.67M +$787K +68,366 +587%
SMC
48
S. Muoio & Co
New York
$1.67M +$921K +80,000 New
Credit Agricole
49
Credit Agricole
France
$1.64M +$904K +78,453 New
PWPCM
50
Perella Weinberg Partners Capital Management
New York
$1.39M +$764K +66,300 New
1
2
3 4 5

VTAE Hedge Fund Activity: Q3 2016 in Review

98 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) for Q3 2016, worth a combined $504M — up 122% from $227M a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new VTAE positions and 20 closed out — a net gain of 27 holders — while 26 added to existing stakes and 18 trimmed.

The largest buyer was Alpine Associates Management, opening a new position worth an estimated $20.6M. The largest seller was Fidelity Investments, cutting an estimated $39.8M.

  • 98 institutional investors held VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) as of Q3 2016, up from 71 in Q2 2016.
  • Funds reported $504M of VITAE PHARMACEUTICALS INC COMMON STOCK stock for Q3 2016, up 122% quarter-over-quarter.
  • 47 funds opened new VITAE PHARMACEUTICALS INC COMMON STOCK positions in Q3 2016 and 20 closed out, a net change of +27 holders.
  • The largest VITAE PHARMACEUTICALS INC COMMON STOCK buyer in Q3 2016 was Alpine Associates Management, an estimated $20.6M added.
  • The largest VITAE PHARMACEUTICALS INC COMMON STOCK seller in Q3 2016 was Fidelity Investments, an estimated $39.8M sold.

Based on aggregated 13F filings for Q3 2016.